Menlo Park, CA, United States of America

Matthew John Siegel

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Stanford, CA (US) (2008 - 2009)
  • San Mateo, CA (US) (2013)
  • Sunnyvale, CA (US) (2014 - 2015)
  • Menlo Park, CA (US) (2014 - 2019)
  • Fremont, CA (US) (2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Innovations and Contributions of Matthew John Siegel

Introduction

Matthew John Siegel is a prominent inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various medical conditions. With a total of 11 patents to his name, Siegel's work has had a substantial impact on healthcare.

Latest Patents

Among his latest patents is the invention of substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists. This invention is particularly useful in treating chemotherapy-induced diarrhea, diabetes, Type II diabetes, gestational diabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, hyperglycemia, obesity, metabolic syndrome, ulcerative colitis, Crohn's disease, disorders associated with parenteral nutrition, especially during short bowel syndrome, and irritable bowel syndrome (IBS). The patent describes a formula where specific variables are defined for the compounds. Another notable patent involves methods and pharmaceutical compositions for treating celiac disease and gluten intolerance. This invention allows for the oral administration of ALV003, which can protect patients suffering from celiac disease and gluten intolerance from the harmful effects of gluten ingestion.

Career Highlights

Matthew John Siegel has worked with esteemed organizations such as Leland Stanford Junior University and Ardelyx, Inc. His career has been marked by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Siegel has collaborated with notable individuals in his field, including Chaitan Khosla and Richard Edward Watts. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Matthew John Siegel's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the treatment of various medical conditions, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…